Description

Cyclodynon (Tranexamic Acid) Oral Drops 50 ml

Ingredients

Active ingredient: Tranexamic Acid
Other ingredients: Purified Water, Citric Acid, Sodium Benzoate

Dosage

Recommended dosage: Consult with a healthcare professional for proper dosage instructions.

Indications

Cyclodynon oral drops are indicated for the treatment of heavy menstrual bleeding (menorrhagia) in women.

Contraindications

Do not use Cyclodynon oral drops if:

• You are allergic to tranexamic acid or any other ingredients in the product.
• You have a history of blood clots.
• You are currently using blood thinners.

Directions

Shake well before use. Take the prescribed amount of oral drops by mouth as directed by your healthcare provider.

Scientific Evidence

Tranexamic acid, the active ingredient in Cyclodynon oral drops, works by helping to reduce heavy menstrual bleeding. Studies have shown that tranexamic acid is effective in significantly reducing blood loss during menstruation without affecting the overall menstrual cycle. Research published in the American Journal of Obstetrics and Gynecology has demonstrated the efficacy of tranexamic acid in treating menorrhagia.

Additional Information

Cyclodynon oral drops provide a convenient and effective way to manage heavy menstrual bleeding. It is important to follow the dosage instructions provided by your healthcare provider to achieve the best results. If you experience any adverse effects or have concerns about using this product, consult with a medical professional for guidance.

Tranexamic acid exerts its pharmacological effects by inhibiting the breakdown of blood clots, thereby reducing excessive bleeding. This mechanism of action makes it particularly useful in the treatment of conditions like menorrhagia. Compared to other treatments, tranexamic acid has been shown to be well-tolerated and effective in managing heavy menstrual bleeding.

Clinical trials have demonstrated the safety and efficacy of tranexamic acid in reducing menstrual blood loss. A study published in the Journal of Thrombosis and Haemostasis concluded that tranexamic acid is a valuable option for the management of menorrhagia due to its ability to effectively reduce bleeding and improve quality of life for women suffering from this condition.